docet

Unit 2 – Developments in retinal screening (~ 19 mins)

• FileDevelopments in retinal screening File
• 
  

  Dr Rebekka Heitmar interviewed by Dr Robert Cubbidge 

  Alzheimer’s disease is the most common cause of dementia, currently affecting more than 520,000 people in the UK. Recent research has shown how changes in the central nervous system related to Alzheimer’s disease may be visualised at the retina. This has implications for the possible use of eye assessments in the screening, and management, of this disease. Aston University has a track record in research into novel approaches in imaging and assessing the retina. Dr Robert Cubbidge and Dr Rebekka Heitmar from Aston University discuss these techniques and the recent developments in retinal screening of Alzheimer’s disease.

• References

   Blair N (2017) Retinal oximetry and vessel diameter measurements with a commercially available scanning laser ophthalmoscope in diabetic retinopathy. Investigative Opthalmology & Visual Science, 58(12), 5556
  

   Mwanza J, Budenz D (2017) New developments in optical coherence tomography imaging for glaucoma. Current Opinion in Ophthalmology
  

   Seshadri S et al. (2015) Ageing effect on flicker-induced diameter changes in retinal microvessels of healthy individuals. Acta Ophthalmologica, 94(1), 35-42
  

• URLKoronyo Y et al. (2017) Retinal amyloid pathology and proof-of-concept imaging of trial in Alzheimer’s disease. JCI Insight. 2(16):e93621. [Accessed Nov 2017] URL Opens in a new window.